Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2458 to 2507 of 6456 in total
Value Type: Measured
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5144.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5634\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 489.26\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1230\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6383.73\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent dystrobrevin binding protein 1; dysbindin. [source:refseq;acc:nm\_032122]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5678.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6161.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08518\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1231\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent probable dimethyladenosine transferase (ec 2.1.1.-) (s- adenosylmethionine-6-n',n'-adenosyl(rrna) dimethyltransferase) (18s rrna dimethylase). [source:swissprot;acc:q9unq2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5132.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5569.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08511\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6383.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 489.26\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1232\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear factor, interleukin 3 regulated. [source:refseq;acc:nm\_005384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5869.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6367.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08494\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5894.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6383.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 489.26\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1233\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent midasin (midas-containing protein). [source:swissprot;acc:q9nu22]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 4483.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4971.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 488.54\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent tyrosinase precursor (ec 1.14.18.1) (monophenol monooxygenase) (tumor rejection antigen ab) (sk29-ab) (lb24-ab). [source:swissprot;acc:p14679]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6004.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6514.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08489\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1234\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent programmed cell death protein 5 (tfar19 protein) (tf-1 cell apoptosis related gene-19 protein). [source:swissprot;acc:o14737]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4749.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5237.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 488.25\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent similar to ecotropic viral integration site 5; neuroblastoma stage 4s gene. [source:refseq;acc:nm\_145245]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5807.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6300.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.08482\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1235\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ecotropic viral integration site 5; neuroblastoma stage 4s gene. [source:refseq;acc:nm\_005665]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent p47 protein isoform a. [source:refseq;acc:nm\_016143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6444.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6932.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 487.99\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1236\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5594.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6067.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08461\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent presenilins associated rhomboid-like protein. [source:refseq;acc:nm\_018622]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6153.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6640.77\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 487.41\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1237\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent tsc22-related inducible leucine zipper protein 2 (tsc-22-like protein thg-1). [source:swissprot;acc:q9y3q8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5873.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6370.31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08457\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1238\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent potential phospholipid-transporting atpase ih (ec 3.6.3.1) (atpase class i type 11a) (atpase is). [source:swissprot;acc:p98196]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6153.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6640.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 487.41\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5873.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6370.31\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.08457\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1239\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5654.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6132.76\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5538.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6025.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 486.71\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1240\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5654.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6132.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08456\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1241\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 6436.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6980.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08451\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serologically defined colon cancer antigen 16. [source:refseq;acc:nm\_006649]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6268.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6755.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 486.63\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1242\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent delta-interacting protein a (hepatitis delta antigen interacting protein a). [source:swissprot;acc:q15834]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 6274.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6760.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 486.16\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 e1 (ec 6.3.2.19) (ubiquitin-protein ligase e1) (ubiquitin carrier protein e1) (ubch6). [source:swissprot;acc:p51965]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11143.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 10276.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08439\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1243\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6371.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 486.14\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2e 3; ubiquitin carrier protein; ubiquitin-protein ligase. [source:refseq;acc:nm\_006357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11143.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 10276.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08439\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1244\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6371.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 486.14\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sirtuin 7; sir2-related protein type 7; sirtuin type 7; sirtuin (silent mating type information regulation 2, s.cerevisiae, homolog) 7; silent mating type information regulation 2, s.cerevisiae, homolog 7; sirtuin silent mating type information regulation 2 homolog 7 (s. cerevisiae). [source:refseq;acc:nm\_016538]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4835.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5243.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08431\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1245\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6371.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 486.14\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4835.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5243.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08431\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1246\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5110.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5596.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 486.13\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent p53-related protein kinase (ec 2.7.1.-) (nori-2). [source:swissprot;acc:q96s44]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5346.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5796.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08429\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1247\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5356.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5842.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 485.92\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6278.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6807.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08421\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1248\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ny-ren-62 antigen (fragment). [source:sptrembl;acc:q9y590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5358.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5843.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 485.55\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein-tyrosine phosphatase, non-receptor type 2 (ec 3.1.3.48) (t- cell protein-tyrosine phosphatase) (tcptp). [source:swissprot;acc:p17706]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6275.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6803.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08415\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1249\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5359.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5844.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 485.25\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4413.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4784.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08407\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1250\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4970.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5455.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 485.13\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent huntingtin interacting protein 1 (hip-i). [source:swissprot;acc:o00291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10733.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 9902.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0839\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1251\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dystrobrevin binding protein 1; dysbindin. [source:refseq;acc:nm\_032122]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5678.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6161.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 483.63\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8618.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 9340.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08385\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1252\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent metaxin 2. [source:swissprot;acc:o75431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7033.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7516.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 483.05\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent zinc finger homeobox protein 1b (smad interacting protein 1) (smadip1) (hrihfb2411). [source:swissprot;acc:o60315]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8618.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 9340.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08385\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1253\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ribokinase (ec 2.7.1.15). [source:swissprot;acc:q9h477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6210.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6693.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 482.98\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transcription factor 8 (nil-2-a zinc finger protein) (negative regulator of il2). [source:swissprot;acc:p37275]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8618.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 9340.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.08385\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent delta-aminolevulinic acid dehydratase (ec 4.2.1.24) (porphobilinogen synthase) (aladh). [source:swissprot;acc:p13716]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5489.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5972.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 482.91\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/